How Abiraterone Works: Unraveling the Mechanism from an Intermediate Perspective
Abiraterone, a prostate cancer treatment, inhibits CYP17 enzymes to disrupt androgen synthesis. It provides therapeutic benefits but may cause fatigue, hypertension, and hepatotoxicity.










